Materials • Major Chemicals
$16.05 ▼ -0.42
(-2.55%)
MKT CAP: $1.83B • VOL: 4.84M
52W L $15 52W H $30
OLN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.78B | $6.54B | $6.83B |
| YoY Revenue Growth % | +3.7% | -4.3% | — |
| Gross Profit | $501.5M | $737.5M | — |
| Gross Margin % | 7.4% | 11.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.3M | $296.5M | $712.1M |
| Operating Margin % | 0.1% | 4.5% | 10.4% |
| Net Income (GAAP) | -$101.1M | $105.0M | $452.0M |
| EBITDA (Normalized) | $186.3M | $452.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $474.2M | $503.2M | $974.3M |
| Capital Expenditures (CapEx) | $226.3M | $195.1M | — |
| Free Cash Flow (FCF) | $247.9M | $308.1M | $974.3M |
| FCF Margin % | 3.7% | 4.7% | 14.3% |
| Return on Invested Capital (ROIC %) | 0.1% | 5.1% | — |
| Cash & Short-Term Equivalents | $167.6M | $175.6M | — |
| Total Debt (Short + Long Term) | $2.72B | $2.71B | — |
| Total Stockholders' Equity | $1.84B | $2.02B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR OLN.